Author:
Zosso-Pavic Matea,Li Qiyu,Atiek Eiman,Wolfer Anita,Rohr Ulrich-Peter
Reference9 articles.
1. R&D briefing 85: new drug approvals in six major authorities 2012–2021: focus on facilitated regulatory pathways and internationalisation. Centre for Innovation in Regulatory Science,2022
2. Project Orbis: Global Collaborative Review Program;de Claro;Clin Cancer Res,2020
3. Comparative expedited regulatory programs of U.S Food & Drug Administration and Project Orbis partners;Hotaki;Ther Innov Regul Sci,2023
4. A decade comparison of regulatory decision patterns for oncology products to all other non-oncology products among Swissmedic, European Medicines Agency, and US Food and Drug Administration;Rohr;Clin Transl Sci,2023
5. Statistical intervals: a guide for practitioners;Hahn,1991
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献